The clinical usefulness of glucose tolerance testing in gestational diabetes to predict early postpartum diabetes mellitus

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 1, 2006, Pages 99-104

  Weijers, Rob N M ^a   Bekedam, Dik J ^a   Goldschmidt, Henk M J ^b   Smulders, Yvo M ^c  

^a Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

^b Tilburg and DeltaLab   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

100 g oral glucose tolerance test; 50 g glucose challenge test; Early postpartum diabetes; Gestational diabetes mellitus; Receiver operating characteristic curve analysis

Indexed keywords

C PEPTIDE; GLUCOSE;

ADULT; ANAMNESIS; ANTHROPOMETRIC PARAMETERS; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ETHNOLOGY; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATERNAL AGE; MEDICAL PARAMETERS; NEWBORN PERIOD; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALIDITY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUERPERIUM; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UNIVARIATE ANALYSIS;

ADULT; BLOOD GLUCOSE; COHORT STUDIES; DIABETES, GESTATIONAL; ETHNIC GROUPS; FEMALE; GESTATIONAL AGE; GLUCOSE TOLERANCE TEST; HUMANS; MIDDLE AGED; NETHERLANDS; POSTPARTUM PERIOD; PREGNANCY; ROC CURVE; TIME FACTORS;

EID: 29444438133     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.019     Document Type: Article

References (21)

1. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes: utility of early postpartum glucose tolerance testing. Diabetes 1995;44:586-91.
2. Schaefer-Graf UM, Buchanan TA, Xiang AH, Peters RK, Kjos SL. Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol 2002;186:751-6.
3. Kjos SL, Buchanan TA, Greenspoon JS, Montoro M, Bernstein GS, Mestman JH. Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months post partum. Am J Obstet Gynecol 1990;163:93-8.
4. Buchanan TA, Xiang A, Kjos SL, Lee WP, Trigo E, Nader I, et al. Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes 1998;47:1302-10.
5. Metzger BE, Cho NH, Boston SM, Radvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 1993;16:1598-605.
6. Damm P, Kuhl C, Bertelsen A, Molsted-Pedersen L. Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol 1992;167:607-16.
7. Cousins L, Baxi L, Chez R, Coustan D, Gabbe S, Harris J, et al. Screening recommendations for gestational diabetes mellitus. Am J Obstet Gynecol 1991;165:493-6.
8. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998;21 (Suppl 2):B161-7.
9. Alberti KG, Skrabalo Z. Standardization of biochemical methods in the diagnosis and management of diabetes. IDF Bulletin 1982;27:17-24.
10. World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Geneva: World Health Organization, 1999.
11. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
12. Weijers RN, Bekedam DJ, Smulders YM. Determinants of mild gestational hyperglycemia and gestational diabetes mellitus in a large Dutch multiethnic cohort. Diabetes Care 2002;25:72-7.
13. Guzick DS. Polycystic ovary syndrome. Obstet Gynecol 2004;103:181-93.
14. Waldhäusl W, Bratusch-Marrain P, Gasic S, Korn A, Nowotny P. Schätzung der Insulinproduktion während oraler Glucosebelastung mittels Lebervenenkathedertechnik und Bestimmung von C-Peptid. In: Grüneklee D, Herzog W, editors. Die Bedeutung der C-Peptidbestimmung für die Diagnostik. Konstanz, Germany: Schnetztor Verlag, 1979:49-57.
15. Treskes M, Adriaansen HJ, van der Leur SJ, Idema RN, Péqué riaux N, Pronk C. Multicentre evaluation of the EBIO plus glucose analyser. Eur J Clin Chem Clin Biochem 1996; 34:777-84.
16. Boyd JC. Mathematical tools for demonstrating the clinical usefulness of biochemical markers. Scand J Lab Invest 1997;57(Suppl 227):46-63.
17. Hanna FW, Peters JR. Screening for gestational diabetes; past, present and future. Diabet Med 2002;19:351-8.
18. Yogev Y, Langer O, Xenakis EM, Rosenn B. Glucose screening in Mexican-American women. Obstet Gynecol 2004;103:1241-5.
19. Campbell MJ, Machin D. Medical statistics. A common-sense approach. Chichester: John Wiley & Sons, 1993:7-31.
20. Greenberg LR, Moore TR, Murphy H. Gestational diabetes: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol 1995;86:97-101.
21. Engelgau MM, Herman WH, Smith PJ, German RR, Aubert RE. The epidemiology of diabetes and pregnancy in the US, 1988. Diabetes Care 1995;18:1029-33.